United States - English - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - paeonia officinalis root (unii: 8r564u2e1p) (paeonia officinalis root - unii:8r564u2e1p) - anal fissures condition listed above or as directed by the physician

United States - English - NLM (National Library of Medicine)

boiron - paeonia officinalis root (unii: 8r564u2e1p) (paeonia officinalis root - unii:8r564u2e1p) - painful hemorrhoids* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

United States - English - NLM (National Library of Medicine)

boiron - paeonia officinalis root (unii: 8r564u2e1p) (paeonia officinalis root - unii:8r564u2e1p) - painful hemorrhoids* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

United States - English - NLM (National Library of Medicine)

meijer, inc. - benzalkonium cl 0.13% w/w              , lidocaine hci 2.5% w/w              , first aid antiseptic, pain relieving spray - first aid to help prevent bacterial contamination or skin infection, and for temporary relief of pain and itching associated with minor: cuts, scrapes, burns, sunburn, skin irritations

United States - English - NLM (National Library of Medicine)

target corporation - benzalkonium cl 0.13% w/w              , lidocaine hci 2.5% w/w          , first aid antiseptic, pain relieving spray - first aid to help prevent bacterial contamination or skin infection, and for temporary relief of pain and itching associated with minor:

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - brain (cerebrum, hypothalamus, medulla oblongata, pineal, transverse fiber) 12x - for the temporary relief of weakened memory, reduced focus or comprehension, confusion, irritability, or occasional headache.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

hahnemann laboratories, inc. - paeonia officinalis root (unii: 8r564u2e1p) (paeonia officinalis root - unii:8r564u2e1p) -

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenoxymethylpenicillin potassium 279mg equivalent to phenoxymethylpenicillin 250 mg (actual formula based on 100% potency); phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg; phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg; phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg - capsule - 250 mg - active: phenoxymethylpenicillin potassium 279mg equivalent to phenoxymethylpenicillin 250 mg (actual formula based on 100% potency) excipient: brilliant blue fcf erythrosine gelatin magnesium stearate opacode white s-1-7085 sunset yellow fcf titanium dioxide active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: capsugel orange op.c027 magnesium stearate active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: capsugel orange op.c027 magnesium stearate active: phenoxymethylpenicillin potassium 277.18mg equivalent to phenoxymethylpenicillin 250 mg excipient: gelatin capsule - maroon - mi01429 gelatin capsule - maroon - mi01430 magnesium stearate - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenoxymethylpenicillin potassium 544.37mg equivalent to phenoxymethylpenicillin 500 mg; phenoxymethylpenicillin potassium 544.36mg equivalent to phenoxymethylpenicillin 500 mg; phenoxymethylpenicillin potassium 554.37mg equivalent to phenoxymethylpenicillin 500 mg - capsule - 500 mg - active: phenoxymethylpenicillin potassium 544.37mg equivalent to phenoxymethylpenicillin 500 mg excipient: gelatin magnesium stearate active: phenoxymethylpenicillin potassium 544.36mg equivalent to phenoxymethylpenicillin 500 mg excipient: capsugel orange op.c027 gelatin iron oxide red magnesium stearate titanium dioxide active: phenoxymethylpenicillin potassium 554.37mg equivalent to phenoxymethylpenicillin 500 mg excipient: maroon capsule acg associated capsules pvt. ltd magnesium stearate - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

European Union - English - EMA (European Medicines Agency)

teva b.v. - fentanyl - pain; cancer - analgesics - effentora is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain. btp is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain. patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg of oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer. ,